XN Health has developed the Phlex diaphragm stimulator, a transtracheal phrenic nerve stimulation device that reactivates the diaphragm in mechanically ventilated patients. This technology improves lung function and reduces the risk of ventilator-induced lung injury by enhancing regional lung ventilation and decreasing the pressure required for mechanical ventilation.
Funding
Funding not disclosed
Founders
Product
Problem
Prolonged mechanical ventilation can lead to ventilator-induced lung injury (VILI) due to unnatural breathing patterns, barotrauma, and poor regional lung ventilation. The lack of diaphragm activation during mechanical ventilation contributes to decreased systemic oxygenation and overall respiratory muscle weakness.
Solution
XN Health's Phlex Diaphragm Stimulator is a transtracheal phrenic nerve stimulation device designed to reactivate the diaphragm in mechanically ventilated patients. By stimulating the phrenic nerve, Phlex promotes a more natural breathing mechanism, improving regional lung ventilation and decreasing the pressure required for mechanical ventilation. This technology aims to prevent ventilator-associated complications, improve lung function, and enhance patient outcomes by strengthening the diaphragm during ventilation.
Target Audience
The primary target audience includes mechanically ventilated patients in the ICU and the healthcare providers who manage their respiratory care.
Features
- Transtracheal phrenic nerve stimulation technology
- Reactivates the diaphragm to support natural breathing during mechanical ventilation
- Minimally invasive design for ease of use
- Seamless integration into existing care workflows
- Improves regional lung ventilation
- Decreases pressure required for mechanical ventilation
- Increases chest cavity volume